- Home
- APLS vs CC Comparison
APLS vs CC Comparison
Compare APLS & CC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLS
- CC
- Stock Information
- Founded
- APLS 2009
- CC 2014
- Country
- APLS United States
- CC United States
- Employees
- APLS N/A
- CC N/A
- Industry
- APLS Biotechnology: Pharmaceutical Preparations
- CC Major Chemicals
- Sector
- APLS Health Care
- CC Industrials
- Exchange
- APLS Nasdaq
- CC Nasdaq
- Market Cap
- APLS 2.9B
- CC 2.3B
- IPO Year
- APLS 2017
- CC N/A
- Fundamental
- Price
- APLS $28.21
- CC $14.04
- Analyst Decision
- APLS Buy
- CC Buy
- Analyst Count
- APLS 19
- CC 8
- Target Price
- APLS $33.63
- CC $18.00
- AVG Volume (30 Days)
- APLS 2.4M
- CC 3.0M
- Earning Date
- APLS 10-30-2025
- CC 11-06-2025
- Dividend Yield
- APLS N/A
- CC 2.49%
- EPS Growth
- APLS N/A
- CC N/A
- EPS
- APLS N/A
- CC N/A
- Revenue
- APLS $754,649,000.00
- CC $5,850,000,000.00
- Revenue This Year
- APLS $24.62
- CC $4.88
- Revenue Next Year
- APLS N/A
- CC $0.21
- P/E Ratio
- APLS N/A
- CC N/A
- Revenue Growth
- APLS 20.02
- CC 0.62
- 52 Week Low
- APLS $16.10
- CC $9.13
- 52 Week High
- APLS $35.72
- CC $22.38
- Technical
- Relative Strength Index (RSI)
- APLS 64.41
- CC 46.64
- Support Level
- APLS $23.85
- CC $12.69
- Resistance Level
- APLS $25.73
- CC $14.31
- Average True Range (ATR)
- APLS 1.28
- CC 0.77
- MACD
- APLS 0.51
- CC -0.05
- Stochastic Oscillator
- APLS 87.59
- CC 44.89
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.
About CC Chemours Company (The)
The Chemours Co is a provider of chemicals. It delivers customized solutions with a wide range of industrial and specialty chemicals products for various markets including coatings, plastics, refrigeration, air conditioning, etc. The company's operating segments include Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. It generates maximum revenue from the Titanium Technologies segment. The Titanium Technologies segment is a producer of TiO2 pigment, a premium white pigment used to deliver whiteness, brightness, opacity, durability, efficiency, and protection across a variety of applications. Geographically, the company derives a majority of its revenue from North America.